Advertisement

A conversation including 39 questions with Anirban Basu

  • A. James O’Malley
  • Aasthaa Bansal
Article

Abstract

At the 2018 International Conference on Health Policy Statistics (ICHPS) held in Charleston, South Carolina, Anirban Basu was awarded the Mid-Career Excellence Award from the American Statistical Association Section on Health Policy Statistics (HPSS). Anirban was exceptionally and uniquely qualified for this award. Highlights include his providing outstanding service to the HPSS, advancing statistical methodology, advancing methodology in other domains of health policy, and performing extensive and highly impactful applied work in medicine and health care. In this interview, we trace Anirban’s upbringing, schooling, early career, and mid-career phases to gain insights into his success. We also sought his opinions on salient topics or issues.

Keywords

Mid Career Excellence Award Health Policy Statistics Section American Statistical Association International Conference on Health Policy Statistics 2018 

Notes

Compliance with ethical standards

Conflict of interest

Neither author has received research grants or awards; honorariums from for-profit companies, non-profit organizations, or government agencies; or owns stock in any company that creates a conflict of interest in relation to this paper. However, Dr. Bansal is a faculty member at the same institution as Dr. Basu and both Dr. O’Malley and Dr. Bansal are members of the ASA Section on Health Policy Statistics along with Dr. Basu. Despite this, neither author declares any conflict of interest.

Ethical approval

This paper does not contain any studies with animals performed by any of the authors. This paper does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from Dr. Basu prior to his interview.

References

  1. Basu, A.: Person-Centered Treatment (PeT) effects using instrumental variables: An application to evaluating prostate cancer treatments. J. Appl. Econom. 29, 671–691 (2014)CrossRefGoogle Scholar
  2. Basu, A.: Welfare implications of learning through solicitation versus diversification in health care. NBER Working paper # 20367. J. Health Econ. 42, 165–173 (2015)CrossRefGoogle Scholar
  3. Basu, A., Meltzer, D.: Implications of spillover effects within the family for medical cost-effectiveness analysis. J. Health Econ. 24, 751–773 (2005)CrossRefGoogle Scholar
  4. Basu, A., Meltzer, D.: Value of information on preference heterogeneity and individualized care. Med. Decis. Mak. 27, 112–127 (2007)CrossRefGoogle Scholar
  5. Basu, A., Rathouz, P.: Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 6, 93–109 (2005)CrossRefGoogle Scholar
  6. Basu, A., Meltzer, H., Dukic, V.: Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approach. Stat. Med. 25, 2886–2910 (2006)CrossRefGoogle Scholar
  7. Basu, A., Heckman, J., Navarro-Lozano, S., Urzua, S.: Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. York Health Econometrics and Data Group (HEDG) Working Paper 07/07 (with Editorial). Health Econ. 16, 1133–1157 (2007)CrossRefGoogle Scholar
  8. Basu, A., Jena, A., Philipson, T.: Impact of comparative effectiveness research on health and healthcare spending. 2010 NBER Working Paper No. w15633. J. Health Econ. 30, 695–706 (2011)CrossRefGoogle Scholar
  9. Terza, J., Basu, A., Rathouz, P.: Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J. Health Econ. 27, 531–543 (2008)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.The Department of Biomedical Data Science and The Dartmouth Institute for Health Policy and Clinical PracticeGeisel School of Medicine at DartmouthLebanonUSA
  2. 2.The Comparative Health Outcomes Policy and Economics (CHOICE) Institute, School of PharmacyUniversity of WashingtonSeattleUSA

Personalised recommendations